MedTrace Logo

Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore

NCT05451927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-04-30

No results posted yet for this study

Summary

This double-blind randomized placebo-controlled trial will test the hypothesis that administration of Phaseolus Vulgaris supplementation to women in Lahore, Pakistan, who are overweight will induce the weight loss (Primary outcome) and changes in body composition (Waist circumference) secondary outcome.

Conditions

  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Phaseolus Vulgaris

Weight loss

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • University of the Punjab

    collaborator OTHER

  • Hafiza Aisha Sadiqa

    lead OTHER

Principal Investigators

  • Aisha Sadiqa, M.Phil · University of the Punjab

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-27
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05451927 on ClinicalTrials.gov